Novo Nordisk, Sanofi Join Elly Lily in Cutting Insulin Prices
- March 17, 2023
Drug manufacturers Novo Nordisk and Sanofi both announced this week plans to cut U.S. list prices for their insulin products amid ongoing pressure from the federal government and the public to lower costs for consumers.
ARTICLE TAGS
You must be logged in to access this content.